NCT06360913View on ClinicalTrials.gov

Blood Spot and Urine Metabolomic Screening Applied to Rare Diseases

NARecruitingINTERVENTIONAL
Enrollment

2,286

Participants

Timeline

Start Date

January 3, 2024

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
Inborn Errors of MetabolismRare Diseases
Interventions
DIAGNOSTIC_TEST

High resolution mass spectrometry

Metabolomics study

Trial Locations (4)

B-1020

NOT_YET_RECRUITING

Hôpital Universitaire des enfants Reine Fabiola (HUDERF-ULB), Brussels

B-1200

RECRUITING

Cliniques universitaires Saint Luc, Brussels

B-6041

NOT_YET_RECRUITING

Institut de Pathologie et de Génétique (IPG), Charleroi

B-4000

NOT_YET_RECRUITING

CHU Liege, Liège

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER